Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 4:29 pm Purchase | 13G | IOVANCE BIOTHERAPEUTICS INC CO IOVA | PERCEPTIVE ADVISORS LLC | 11,979,415 4.7% | 2,007,635 (+20.13%) | View |
| 2024-02-14 4:27 pm Sale | 13G | VERONA PHARMA PLC SPONSORED AD VRNA | PERCEPTIVE ADVISORS LLC | 3,866,214 4.8% | -596,452 (-13.37%) | View |
| 2024-02-14 4:27 pm Unchanged | 13G | SPYRE THERAPEUTICS, INC SYRE | PERCEPTIVE ADVISORS LLC | 2,606,679 7.2% | 0 (Unchanged) | View |
| 2024-02-12 4:16 pm Purchase | 13G | RHYTHM PHARMACEUTICALS INC RYTM | PERCEPTIVE ADVISORS LLC | 3,260,013 5.5% | 3,260,013 (New Position) | View |
| 2024-02-09 7:51 pm Purchase | 13D | TRINITY BIOTECH TRIB | PERCEPTIVE ADVISORS LLC | 56,000,000 26.8% | 56,000,000 (New Position) | View |
| 2024-02-05 4:14 pm Purchase | 13D | ASTRIA THERAPEUTICS INC ATXS | PERCEPTIVE ADVISORS LLC | 6,485,420 11.9% | 2,857,727 (+78.78%) | View |
| 2024-01-29 4:53 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | PERCEPTIVE ADVISORS LLC | 4,022,066 6.7% | 4,022,066 (New Position) | View |
| 2024-01-19 4:37 pm Purchase | 13G | FUSION PHARMACEUTICALS INC FUSN | PERCEPTIVE ADVISORS LLC | 4,737,194 6.5% | 4,737,194 (New Position) | View |
| 2024-01-12 5:11 pm Purchase | 13D | SOLID BIOSCIENCES INC SLDB | PERCEPTIVE ADVISORS LLC | 6,925,028 18.6% | 3,423,763 (+97.79%) | View |
| 2024-01-02 4:11 pm Purchase | 13G | NUVALENT INC NUVL | PERCEPTIVE ADVISORS LLC | 2,917,991 5.1% | 2,917,991 (New Position) | View |
| 2023-12-29 5:15 pm Purchase | 13D | ATHIRA PHARMA INC ATHA | PERCEPTIVE ADVISORS LLC | 5,458,448 14.3% | 647,299 (+13.45%) | View |
| 2023-12-26 4:15 pm Purchase | 13G | CELCUITY INC CELC | PERCEPTIVE ADVISORS LLC | 1,441,300 5.7% | 1,441,300 (New Position) | View |
| 2023-12-13 3:50 pm Purchase | 13G | SPYRE THERAPEUTICS, INC SYRE | PERCEPTIVE ADVISORS LLC | 2,606,679 7.2% | 2,606,679 (New Position) | View |
| 2023-12-06 4:15 pm Purchase | 13G | APPLIED THERAPEUTICS INC APLT | PERCEPTIVE ADVISORS LLC | 4,580,249 5.9% | 4,580,249 (New Position) | View |
| 2023-11-27 4:16 pm Purchase | 13G | EVOLUS INC EOLS | PERCEPTIVE ADVISORS LLC | 3,086,604 5.4% | 3,086,604 (New Position) | View |
| 2023-11-17 6:59 pm Purchase | 13D | VBI VACCINES INC CDA COM VBIV | PERCEPTIVE ADVISORS LLC | 1,381,355 5.8% | 1,381,355 (New Position) | View |
| 2023-11-16 9:18 pm Purchase | 13D | NAUTILUS BIOTECHNOLOGY INC NAUT | PERCEPTIVE ADVISORS LLC | 12,594,211 10.1% | 3,683,060 (+41.33%) | View |
| 2023-11-14 4:15 pm Purchase | 13G | CARGO THERAPEUTICS INC CRGX | PERCEPTIVE ADVISORS LLC | 3,246,168 8.4% | 3,246,168 (New Position) | View |
| 2023-10-23 4:20 pm Unchanged | 13D | SOLENO THERAPEUTICS INC PA SLNO | PERCEPTIVE ADVISORS LLC | 3,074,542 10.1% | 0 (Unchanged) | View |
| 2023-10-18 6:07 pm Sale | 13G | ALDEYRA THERAPEUTICS, INC ALDX | PERCEPTIVE ADVISORS LLC | 8,593,586 14.7% | -2,756,499 (-24.29%) | View |